The coming of age of virus-like particle vaccines (Q37309265)

19 August 2017

1 reference

title

The coming of age of virus-like particle vaccines (English)

1 reference

19 August 2017

0 references

0 references

2

Martin F Bachmann

1 reference

19 August 2017

Gary T Jennings

1

1 reference

19 August 2017

1 May 2008

1 reference

19 August 2017

1 reference

19 August 2017

389

1 reference

19 August 2017

521-536

1 reference

19 August 2017

5

1 reference

Renin-angiotensin vaccine: old story, new project 'efficacy versus safety'.

19 August 2017

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

A nicotine conjugate vaccine reduces nicotine distribution to brain and attenuates its behavioral and cardiovascular effects in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

Specific cellular stimulation in the primary immune response: experimental test of a quantized model

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

The influence of virus structure on antibody responses and virus serotype formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

Abeta vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

Cross-presentation of virus-like particles by skin-derived CD8(-) dendritic cells: a dispensable role for TAP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

Natural supramolecular building blocks. Cysteine-added mutants of cowpea mosaic virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

Role of Toll-like receptors in costimulating cytotoxic T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

T helper cell-independent neutralizing B cell response against vesicular stomatitis virus: role of antigen patterns in B cell induction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

Randomized double-blind placebo-controlled study of an angiotensin immunotherapeutic vaccine (PMD3117) in hypertensive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

Virus and virus-like particle-based immunogens for Alzheimer's disease induce antibody responses against amyloid-beta without concomitant T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

A Viral Platform for Chemical Modification and Multivalent Display

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

Mosaic hepatitis B virus core particles presenting the complete preS sequence of the viral envelope on their surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

The economic impact of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

HBV core particles as a carrier for B cell/T cell epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

Efficient homologous prime-boost strategies for T cell vaccination based on virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

Influenza vaccines: a review and rationale for use in developed and underdeveloped countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

Stop codon insertion restores the particle formation ability of hepatitis B virus core-hantavirus nucleocapsid protein fusions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

Neutralizing antiviral B cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

Structures of virus and virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

Multiple chemical forms of hepatitis B surface antigen produced in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

Safety, immunogenicity and efficacy of a pre-erythrocytic malaria candidate vaccine, ICC-1132 formulated in Seppic ISA 720.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

Therapeutic potential of Toll-like receptor 9 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

Passive immunization against nicotine prevents nicotine alleviation of nicotine abstinence syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

Critical role for activation of antigen-presenting cells in priming of cytotoxic T cell responses after vaccination with virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

Active immunization against nicotine prevents reinstatement of nicotine-seeking behavior in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

Virus-like particles: passport to immune recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

Designing recombinant vaccines with viral properties: a rational approach to more effective vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

Native display of complete foreign protein domains on the surface of hepatitis B virus capsids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

Immunotherapy for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

21 January 2018

Identifiers

DOI

10.1515/BC.2008.064

1 reference

19 August 2017

1 reference

PubMed ID

18953718